In a study by Htet et al, which examined how hepcidin correlates with anemia after 12 weeks of iron supplementation among adolescent girls, a non-negligible number of girls (38%) showed evidence of subclinical inflammation.13 However, this subclinical inflammation turned out not to be associated with hepcidin concentration, nor with anemia. The gene discussed is HAMP; the disease is anemia.